Cargando…
Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Osteosarcoma
BACKGROUND: Six cell surface receptors, human epidermal growth factor receptor-2 (Her-2), platelet-derived growth factor receptor-β (PDGFR-β), insulin-like growth factor-1 receptor (IGF-1R), insulin receptor (IR), c-Met, and vascular endothelial growth factor receptor-3 (VEGFR-3), previously demonst...
Autores principales: | Zvi, Yoav, Ugur, Elif, Batko, Brian, Gill, Jonathan, Roth, Michael, Gorlick, Richard, Hall, David, Tingling, Janet, Barkauskas, Donald A., Zhang, Jinghang, Yang, Rui, Hoang, Bang H., Geller, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872755/ https://www.ncbi.nlm.nih.gov/pubmed/33603563 http://dx.doi.org/10.1155/2021/8324348 |
Ejemplares similares
-
Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma
por: Zhang, Yidan, et al.
Publicado: (2018) -
Variability in the reported management of pulmonary metastases in osteosarcoma
por: Bhattasali, Onita, et al.
Publicado: (2015) -
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
por: Koirala, Pratistha, et al.
Publicado: (2016) -
The effect of bone morphogenetic protein-2 on osteosarcoma metastasis
por: Gill, Jonathan, et al.
Publicado: (2017) -
Skp2 Depletion Reduces Tumor-Initiating Properties and Promotes Apoptosis in Synovial Sarcoma
por: Wang, Jichuan, et al.
Publicado: (2020)